Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,755 | -13,005 | -8,289 | -26,422 | -17,297 |
| Depreciation Amortization | 5,198 | 3,169 | 1,633 | 3,624 | 1,865 |
| Accounts receivable | -1,733 | 4,202 | 4,918 | -10,089 | -12,686 |
| Other Working Capital | -13,347 | -13,414 | -18,217 | -3,534 | -19,771 |
| Other Operating Activity | 8,196 | -632 | -3,177 | 16,003 | 16,739 |
| Operating Cash Flow | $-18,441 | $-19,680 | $-23,132 | $-20,418 | $-31,150 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -54 | -24 | -7 | -324 | -214 |
| Purchase Of Investment | -145,414 | -86,527 | -67,452 | -169,320 | -93,320 |
| Sale Of Investment | 178,960 | 116,676 | 99,830 | 94,624 | 16,551 |
| Purchase Sale Intangibles | -3,026 | -1,643 | -1,360 | -4,762 | -3,008 |
| Other Investing Activity | -3,026 | -1,643 | -1,337 | -4,577 | -3,473 |
| Investing Cash Flow | $30,466 | $28,482 | $31,034 | $-79,597 | $-80,456 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 15,000 | 15,000 |
| Debt Repayment | -12,273 | -12,273 | -12,273 | -2,727 | -682 |
| Common Stock Issued | 585 | 295 | 90 | 101,551 | 101,582 |
| Other Financing Activity | -25,751 | -25,741 | -25,641 | 4,018 | -1,137 |
| Financing Cash Flow | $-37,439 | $-37,719 | $-37,824 | $117,842 | $114,763 |
| Beginning Cash Position | 52,203 | 52,203 | 52,203 | 34,376 | 34,376 |
| End Cash Position | 26,789 | 23,286 | 22,281 | 52,203 | 37,533 |
| Net Cash Flow | $-25,414 | $-28,917 | $-29,922 | $17,827 | $3,157 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,441 | -19,680 | -23,132 | -20,418 | -31,150 |
| Capital Expenditure | -54 | -24 | -7 | -324 | -214 |
| Free Cash Flow | -18,495 | -19,704 | -23,139 | -20,742 | -31,364 |